IQVIA Holdings Inc header image

IQVIA Holdings Inc

IQV

Equity

ISIN US46266C1053 / Valor 39103858

New York Stock Exchange, Inc (2024-11-21)
USD 197.60+1.66%

IQVIA Holdings Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

IQVIA Holdings Inc is a leading global provider of advanced analytics, technology solutions, and clinical research services to the healthcare industry. The company's Innovation Hub facilitates collaboration between start-ups and its extensive network of assets, resources, clients, and partners to drive innovation in healthcare. Additionally, IQVIA's Human Data Science Cloud offers healthcare-grade analytics, tools, and data management solutions to deliver global data at scale. With a focus on leveraging data and technology to improve healthcare outcomes, IQVIA plays a crucial role in shaping the future of the industry.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (20.08.2024):

Revenue Growth

IQVIA Holdings Inc. reported revenue of $3,814 million for the second quarter of 2024, marking a 2.3 percent increase on a reported basis and a 3.5 percent increase at constant currency compared to the same quarter in 2023. This growth was driven by strong performance in the Technology & Analytics Solutions (TAS) and Research & Development Solutions (R&DS) segments.

Net Income and Earnings

For the second quarter of 2024, IQVIA Holdings Inc. achieved a GAAP Net Income of $363 million, translating to a GAAP Diluted Earnings per Share of $1.97. On an adjusted basis, the company reported an Adjusted Net Income of $487 million and an Adjusted Diluted Earnings per Share of $2.64.

Segment Performance

IQVIA Holdings Inc.'s R&DS segment reported revenue of $2,147 million for the second quarter of 2024, reflecting a 2.4 percent increase on a reported basis and a 3.3 percent increase at constant currency. The TAS segment also showed robust growth with revenue of $1,495 million, up 2.7 percent on a reported basis and 3.8 percent at constant currency.

Contracted Backlog

As of June 30, 2024, IQVIA Holdings Inc.'s R&DS contracted backlog, including reimbursed expenses, stood at $30.6 billion, representing a 7.7 percent increase year-over-year and an 8.1 percent increase at constant currency. The company expects approximately $7.8 billion of this backlog to convert to revenue within the next twelve months.

Full-Year 2024 Guidance

IQVIA Holdings Inc. updated its full-year 2024 guidance, projecting revenue to be between $15,425 million and $15,525 million. The company also expects Adjusted EBITDA to range from $3,705 million to $3,765 million, and Adjusted Diluted Earnings per Share to be between $11.10 and $11.30.

Summarized from source with an LLMView Source

Key figures

-4.75%1Y
-26.3%3Y
37.7%5Y

Performance

29.2%1Y
30.6%3Y
33.9%5Y

Volatility

Market cap

35864 M

Market cap (USD)

Daily traded volume (Shares)

363,463

Daily traded volume (Shares)

1 day high/low

197.91 / 192.15

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Novartis Inc
Novartis Inc Novartis Inc Valor: 567514
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.74%USD 103.85
Udemy Inc
Udemy Inc Udemy Inc Valor: 114176816
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%USD 7.55
Scilex Holding Company
Scilex Holding Company Scilex Holding Company Valor: 123144552
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.32%USD 0.55
Spire Healthcare Group PLC
Spire Healthcare Group PLC Spire Healthcare Group PLC Valor: 24881418
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.23%GBP 2.17
KK Fancl
KK Fancl KK Fancl Valor: 960002
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.04%JPY 2,794.00
Laboratorios Farmaceuticos Rovi, SA
Laboratorios Farmaceuticos Rovi, SA Laboratorios Farmaceuticos Rovi, SA Valor: 3591807
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.24%EUR 61.85
Quanterix Corporation
Quanterix Corporation Quanterix Corporation Valor: 39127916
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
6.35%USD 11.72
Nano-X Imaging Ltd.
Nano-X Imaging Ltd. Nano-X Imaging Ltd. Valor: 56410599
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.58%USD 6.16
Olaplex Holdings Inc
Olaplex Holdings Inc Olaplex Holdings Inc Valor: 113471584
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
9.89%USD 2.00
ModivCare Inc
ModivCare Inc ModivCare Inc Valor: 59168951
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
7.11%USD 17.47